ArticleAmerican journal of cancer research2024

Updated outcomes and exploratory analysis of RENMIN-215: tislelizumab plus fruquintinib and fecal microbiota transplantation in refractory microsatellite stable metastatic colorectal cancer.

Wensi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.